Therapeutic Peptides intermediate
Peptide Autoimmune Therapeutics
Therapeutic peptides for autoimmune disease treatment including tolerogenic peptides and immunomodulatory agents.
By Encyclopeptide Editorial | 1 min read
autoimmune tolerogenic immunomodulatory therapeutic antigen-specific
Overview
Tolerogenic peptides represent a promising approach to treat autoimmune diseases by inducing antigen-specific immune tolerance without broad immunosuppression.
Clinical Applications
| Disease | Peptide Target | Clinical Status |
|---|---|---|
| Type 1 diabetes | Insulin/GAD65 epitopes | Phase 2/3 |
| Multiple sclerosis | Myelin peptides | Phase 2/3 |
| Rheumatoid arthritis | Collagen epitopes | Phase 2 |
Challenges
- Peptide stability
- Delivery optimization
- Patient selection
- Manufacturing scalability
Chemical Identity
| Property | Value |
|---|---|
| Name | Peptide Autoimmune Therapeutics |
| Category | Therapeutic Peptides |
References
- Encyclopeptide Database. “Peptide Autoimmune Therapeutics” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Peptide Autoimmune Therapeutics with interactive quizzes on Wikipept.
Take a Quiz on Wikipept